Literature DB >> 19151075

Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors.

Leslie Audigane1, Benoît-Gilles Kerfant, Aziza El Harchi, Ilka Lorenzen-Schmidt, Gilles Toumaniantz, Anne Cantereau, Daniel Potreau, Flavien Charpentier, Jacques Noireaud, Chantal Gauthier.   

Abstract

The beta(3)-adrenoceptors (beta(3)-ARs) have been identified and characterized in the human heart. Specific beta(3)-AR stimulation, unlike beta(1)-AR or beta(2)-AR stimulation, decreases cardiac contractility, partly via the G(i)-NO pathway. However, the precise role of cardiac beta(3)-ARs is not yet completely understood. Indeed, under normal conditions, the beta(3)-AR response is present only to a very low degree in rats and mice. Therefore, we evaluated whether beta(3)-ARs were present and functional in rabbit ventricular cardiomyocytes, and whether the rabbit could serve as a relevant model for the study of cardiac beta(3)-ARs. We used RT-PCR and Western blot to measure the beta(3)-AR transcripts and protein levels in rabbit ventricular cardiomyocytes. We also analysed the effect of beta(3)-AR stimulation using isoproterenol in combination with nadolol or SR 58611A on cardiomyocyte shortening, Ca(2+) transient, L-type Ca(2+) current (I(Ca,L)), delayed rectifier potassium current (I(Ks)) and action potential duration (APD). For the first time, we show that beta(3)-ARs are expressed in rabbit ventricular cardiomyocytes. The mRNA and protein sequences present a high homology to those of rat and human beta(3)-ARs. Furthermore, beta(3)-AR stimulation decreases cardiomyocyte shortening, Ca(2+) transient and I(Ca,L) amplitudes, via a G(i)-NO pathway. Importantly, beta(3)-AR stimulation enhances I(Ks) amplitude and shortens the APD. Taken together, our results indicate that the rabbit provides a relevant model, easily used in laboratories, to study the roles of cardiac beta(3)-ARs in physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151075     DOI: 10.1113/expphysiol.2008.045179

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  8 in total

Review 1.  Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies.

Authors:  Chantal Gauthier; Bertrand Rozec; Boris Manoury; Jean-Luc Balligand
Journal:  Curr Heart Fail Rep       Date:  2011-09

2.  β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A Fry; Elisha J Hamilton; Gemma A Figtree; Helge H Rasmussen
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-10       Impact factor: 4.249

3.  β3-Adrenoceptor Impairs Mitochondrial Biogenesis and Energy Metabolism During Rapid Atrial Pacing-Induced Atrial Fibrillation.

Authors:  Jingmei Dong; Jingjing Zhao; Miaomiao Zhang; Guangzhong Liu; Xiaobing Wang; Yixi Liu; Ning Yang; Yongwu Liu; Guanqi Zhao; Jiayu Sun; Jingpu Tian; Cheping Cheng; Lin Wei; Yue Li; Weimin Li
Journal:  J Cardiovasc Pharmacol Ther       Date:  2015-06-30       Impact factor: 2.457

4.  The Trend of β3-Adrenergic Receptor in the Development of Septic Myocardial Depression: A Lipopolysaccharide-Induced Rat Septic Shock Model.

Authors:  Ni Yang; Xiao-Lu Shi; Bing-Lun Zhang; Jian Rong; Tie-Ning Zhang; Wei Xu; Chun-Feng Liu
Journal:  Cardiology       Date:  2018-03-22       Impact factor: 1.869

5.  CL316,243, a selective β3-adrenoceptor agonist, activates protein translation through mTOR/p70S6K signaling pathway in rat skeletal muscle cells.

Authors:  Maria Concetta Miniaci; Mariarosaria Bucci; Rita Santamaria; Carlo Irace; Anna Cantalupo; Giuseppe Cirino; Pietro Scotto
Journal:  Pflugers Arch       Date:  2013-01-19       Impact factor: 3.657

6.  β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure.

Authors:  Satoshi Masutani; Heng-Jie Cheng; Atsushi Morimoto; Hiroshi Hasegawa; Qing-Hua Han; William C Little; Che Ping Cheng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

7.  β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Carmine Gentile; Natasha A Fry; Elisha J Hamilton; Clare L Hawkins; Gemma A Figtree
Journal:  J Am Heart Assoc       Date:  2016-02-19       Impact factor: 5.501

8.  A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.

Authors:  Marcela K Preininger; Rajneesh Jha; Joshua T Maxwell; Qingling Wu; Monalisa Singh; Bo Wang; Aarti Dalal; Zachary T Mceachin; Wilfried Rossoll; Chadwick M Hales; Peter S Fischbach; Mary B Wagner; Chunhui Xu
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.